Recognized Laboratory Diagnostics Leaders 2025

Dr. Roshan Daniel is a Clinical Geneticist based in Thiruvananthapuram, Kerala, where he independently heads the Department of Medical Genetics and Precision Medicine at KIMSHealth, one of Kerala's largest and most respected hospital groups. He is the founder of Genetidoc, India's largest network of online genetics specialists, built to make expert genetic care accessible, affordable, and personal for families across the country. He completed his Doctor of Medicine (MD) in Pediatrics and his Doctorate of Medicine (DM) in Medical Genetics at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh — one of India's most prestigious postgraduate medical institutions. In 2025, he earned the European Board of Medical Genetics and Genomics (ECMGG) certification and a Postgraduate Diploma in Precision Oncology, placing him among a small group of Indian geneticists with formal recognition at an international standard. Dr. Daniel's clinical philosophy centres on translating high-end genomic science into actionable, human-centred care — whether guiding a previvor (a person at high genetic risk for cancer) through risk management, resolving a complex paediatric diagnostic case, or helping a couple navigate their reproductive options. He is an author of peer-reviewed publications on rare mitochondrial disorders, Schwartz–Jampel Syndrome, and RASopathies, and is an active mentor to clinicians and medical students through workshops, webinars, and structured coaching programmes. Areas of Expertise Precision Oncology and Hereditary Cancer Integration of genomic insights for personalised cancer risk assessment, surveillance, and management, including care for previvors navigating hereditary cancer syndromes such as BRCA-related cancers and Lynch syndrome. Reproductive and Prenatal Genetics Specialist genetic testing and counselling for congenital anomalies, high-risk pregnancies, and preconception planning. Paediatric Rare Diseases Diagnosis and management of syndromic conditions, developmental delays, and skeletal dysplasias in children, developed across years of practice at a tertiary genetics centre. Neurometabolic Disorders and Neurogenetics Evaluation and management of hereditary neurological conditions across paediatric and adult populations, including complex metabolic presentations with neurological involvement.

Skilled, highly knowledgeable, and analytical professional with over fourteen years experience in the healthcare sector. Primary expertise in providing strategic insights and actionable information to life science companies. Proficient in molecular diagnostics, point of care diagnostics, genomics, immunoassays, oncology diagnostics, cardiology diagnostics, infectious disease diagnostics and personalized medicine. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations. Specialties: Extensive knowledge in the genomics, in-vitro diagnostics space. Demonstrated success in managing teams and clients, assessing business models identifying market opportunities/risks and developing strategies to optimize market penetration, competitive advantage and profit.

As a medical laboratory scientist, I perform laboratory tests that help diagnose, treat, and prevent diseases. I analyze blood, urine, tissues, and other body fluids using microscopes, automated machines, and chemical methods. I look for abnormalities, detect infections, and monitor patient health. Accuracy and attention to detail are essential in everything I do, from handling samples to following safety protocols. I also maintain lab equipment, ensure quality control, and interpret results for physicians. My work directly impacts patient care, as the data I provide helps doctors make informed decisions for treatment and disease prevention.

Founder of MDx CRO a specialized clinical research and regulatory consultancy dedicated to the medtech IVD sector. As a seasoned consultant in clinical and regulatory affairs, I am experienced in navigating complex regulatory challenges for top IVD companies. I have the privilege of serving as an external expert for the EU Commission and having lead global regulatory projects at BSI, one of the largest Notified Bodies as an IVDR CE mark technical expert. My portfolio of satisfied clients includes renowned companies such as Biomerieux, Cepheid, Leica (Danaher), Hologic, Grifols, Abbott, Beckman Coulter, ThermoFisher Scientific, Instrumentation Laboratory (Werfen), Roche Diagnostics, Alere, and more. I am passionate about simplifying science and regulation for my clients, delivering tailored solutions that help them stay ahead of the competition. My secret to success is building relationships based on trust, expertise and kindness. My clinical background, combined with 15+ years in the IVD industry and regulatory authorities, makes me a valuable resource for clients of all sizes. Let's connect and find out how I can help you navigate the ever-evolving world of IVD and MedTech 💬

*Board-Certified Family Medicine Physician (ABFM) with 14+ years clinical experience (based in Chicago, IL) *Named Castle Connolly Top Doctor (2024, 2025) *Medical Media Commentator seen on/in ABC 7, Fox 32, CBS 2, WGN 9, The Chicago Tribune , Chicago Sun Times, and Everyday Health; including a nationwide 25 interview satellite media tour (TV & radio, November 2025) *Premedical Student Mentor, Urban Bridges Medical Mentoring Program Dr. Rene is a board-certified Family Medicine physician and Fellow of the American Academy of Family Physicians (FAAFP) with 14+ years of clinical experience. She provides comprehensive primary care for Medicare-eligible patients at Oak Street Health's Avalon Park location in Chicago, specializing in chronic disease management, preventive care, healthcare equity, and access for underserved communities. After overcoming 50 medical school rejections, Dr. Rene graduated from Indiana University School of Medicine and completed residency training at Ascension Saint Joseph Hospital - Chicago. She developed the L.Y.M.I.T.S. Method—a framework for transforming limitations into your greatest strengths. She mentors aspiring physicians through the Urban Bridges Medical Mentoring Program. Dr. Rene has appeared as a medical expert on ABC 7, Fox 32, CBS 2, and WGN 9 Chicago and recently completed a 25-interview national satellite media tour. She is available for expert commentary on resilience in healthcare, medical education equity, resilience and overcoming failure, healthcare access for underserved populations, and diversity in medicine.

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Dr. Sarassawadee Suwanjinda ("Dr. Petch") is Co-Founder and Chief Medical Strategy Officer at Healthi Life, Bangkok's Urban Longevity House. Certifications: - International Board of Lifestyle Medicine (IBLM) - International Society for Stem Cell Application (ISSCA) - Certified Board of Anti-Aging Medicine (CBAM) - American Academy of Aesthetic Medicine (AAAM) - Certificate in Aesthetic Medicine 10+ years of clinical experience in longevity, regenerative, functional, and lifestyle medicine. Available for expert medical commentary on: - Longevity medicine and healthspan extension - Stem cell and exosome therapy safety - NAD+ IV therapy and mitochondrial health - Peptide therapy and physician oversight (Tirzepatide, Retatrutide, BPC-157) - Hormone optimization (testosterone, perimenopause) - 300+ biomarker health check-ups - Functional medicine for chronic conditions Located in Ekkamai, Bangkok. Serving 50+ nationalities.

R.G.C.C. International GmbH is a leading company in analysis of circulating tumor cells as well as Cancer Stem Cells.Through our high quality analysis at R.G.C.C. International GmbH we are able to offer a full ranges of services to the R & D, clinical, and pharmaceutical industry.By using the most advanced and innovative technologies of molecular and cellular

Nagourney Cancer Institute (formerly Rational Therapeutics) has pioneered the use of human tumor primary cultures for the study of drug actions and drug synergy. Using Functional Profiling to conduct Ex Vivo Analyses of Programmed Cell Death (EVA/PCD), this platform has been shown, in the peer reviewed literature, to correlate significantly with patient response, time to progression and survival. EVA/PCD analyses have also accurately identified many of the today's most widely used cancer therapies, including purine-alkylator therapies for lymphatic malignances and the wide use of platin-gemcitabine based therapies in breast, ovary and GI malignancies. Rational Therapeutics is now enaged in analyses of signal transduction inhibitor combinations, the results of which, will revolutionize cancer therapy and drug development for cancer.

Global human resources and association leader with a broad range of strategic HR and governance experience involving board and volunteer governance, organizational development, employee engagement, DEI/workplace culture, benefits, compensation, recruitment, policy development, and compliance. Serve as trusted advisor to CEO and senior leadership. Experience in both U.S. and international HR. Passionate about building high-performing and inclusive work cultures that foster trust, collaboration, and transparency, as well as boost employee retention. Certified Association Executive (CAE). DiSC certified. SHRM Senior Certified Professional (SHRM-SCP)

I am the Co-Founder and Chief Product Officer at Mantalys, an AI start-up based in Toulouse, France dedicated to bringing lightweight, high-performance AI solutions to biomedical image analysis. With a PhD in neuro-immunology and five years of post-doctoral research experience in tumor immunology, I bring deep biomedical expertise to the computer vision team - bridging science and technology to unlock real world insights and extract actionable intelligence from biomedical images.

Clinically trained veterinarian with experience in gastroenterology, internal medicine, and emergency care. Veterinary physician-scientist specializing in clinical research, diagnostic development, and translational medicine in companion animals, supporting research initiatives in oncology and internal medicine. Skilled in clinical sample characterization and biobank operations, including medical record review of 4,000+ veterinary cases and collaboration with academic and clinical partners. Holds a PhD in Biomedical Sciences focused on cell biology and organoid technology with multiple pending patents, with experience in disease modeling and scientific publication. Regularly collaborates with senior leadership to align cross-functional teams and advance complex research initiatives, complemented by an MBA focused on strategy and project management.

Andrew Rocco, DVM is a veterinarian and founder of GrassDx (grassdx.com), a free AI-powered lawn diagnosis tool that identifies 47+ lawn conditions from a photo. He applied the same pattern-recognition methodology used in clinical veterinary medicine to lawn care diagnostics — building a tool that gives homeowners specific, localized diagnoses rather than generic advice. He practices as medical director at North Sound Veterinary Urgent Care in Mill Creek, WA, and holds a DVM from Washington State University with background in emergency medicine, internal medicine, and diagnostic imaging. He speaks to: lawn care and turf disease, AI tools for homeowners, diagnostic methodology applied outside medicine, veterinary medicine and emergency care, and bootstrapped entrepreneurship.

I am an entrepreneur in the medical industry working on creating a new way to approach healthcare and wellness. The company is called Selph, it is a healthcare revolution to provide individuals with the tools to optimise their health. I am a trained General Practitioner and prior to my medical training I completed a PhD looking at the impact of nutrition and probiotic supplementation on metabolism and the developing immune system. I am fascinated by the interaction between the microbiome and health and was a past member of the science translational committee for the International Scientific Association for Probiotics and Prebiotics as well as a founding member of the International Cancer Microbiome Consortium. During my clinical training I became excited in the importance of the mind in physical health and vice versa and so I trained as an accredited mindfulness teacher specialising in mindfulness for stress and mindfulness for chronic pain.

Founder of IngredientMD, a supplement intelligence platform powdered by most clinical data available. What's important, we communicate in language humans will understand instead. It all starts from individual ingredients instead of product name, claims, and anything else. Product is what's inside instead of what perception is being made. In our analysis of 500+ supplement products, we found 42% had at least one key ingredient below clinically studied doses. I focus on bringing evidence-based analysis to consumer supplement decisions.

Mrs. Durga Chavali is an internationally recognized IT healthcare leader and AI researcher with nearly two decades of experience and a proven track record of implementing enterprise-level technology strategies that improve efficiency, drive digital transformation, and enable data-driven decision-making. She is the proven leader in implementing complex, high-stakes healthcare IT projects with significant ROI, guiding enterprise-level initiatives from concept to execution, and enabling organizations to make informed decisions that optimize operations, reduce risk, and enhance financial and clinical outcomes. Ms. Chavali is a Doctor of Health Care Administration and a results-driven healthcare IT executive who consistently delivers measurable improvements in clinical outcomes, operational efficiency, and financial performance by making strategic, data-informed decisions that optimize enterprise-level processes and drive organizational success. She has been honored with the Fellow Honorary of IETE, Distinguished Fellow of SCRS, and Honorary Inducted Member of Phi Kappa Phi. Mrs. Chavali has been recognized for thought leadership through publications in leading healthcare and AI journals and business magazines, translating complex research into actionable strategies that improve patient outcomes, operational efficiency, and financial performance in enterprise healthcare settings. Mrs. Chavali is also a trusted advocate and coach in the AI era, leveraging a strong research background to guide organizations in adopting innovative AI-driven strategies and driving business transformation toward measurable success Mrs. Chavali is an award-winning healthcare IT leader, recognized with the Inspera and ITA Awards for Distinguished Research and Breakthrough Innovation, pioneering innovative solutions that integrate research and industry expertise to drive AI-powered analytics, predictive insights, and compliance automation, delivering measurable improvements in care quality, operational efficiency, and financial outcomes. Ms. Chavali has been further recognized by the most popular and high-circulation media and featured in respected industry publications such as TechBullion and TechTimes, leveraging published insights on healthcare IT, AI, and data-driven innovation to influence cross‑industry discourse and drive enterprise‑level transformation. Mrs. Chavali contributes to organizations such as IEEE and ACM and supports the community through her expertise.

Dr. Lynsey Johnson, DNP, FNP-C, CEO/Founder of PCOS Sisters Telehealth Clinic & Wellness Center (Serving 11 states) and Emory University Community Research Partner, has spoken at and been recognized at multiple local & national conferences and events. Including PCOS CON 2025, the “Ask The Experts Panel” with 11Alive News, and was featured in “What’s It Like Living with PCOS? Here’s What You Had to Say,” published in New York Magazine’s The Cut and was a finalist in the Top 10 Women's Health Innovations in the U.S. category at the 2024 USA Women's Health Innovation Summit as well as being named Top 3 Women Shaping the Future of HealthCare in the Ignite Gulf Coast Competition. With September being PCOS Awareness Month, Dr. Johnson is available for interviews to speak about PCOS. Topics Dr. Johnson can speak to your audience about: Dr. Johnson’s partnership with Emory University School of Nursing on research entitled “Weight loss effects of semaglutide in combination with lifestyle changes in obese PCOS patients utilizing a telehealth care delivery model”. Dr. Johnson’s PCOS Screening Tool for patient self-assessment and screening by non-specialized medical providers, such as primary care physicians. The PCOS Trailblazers 5K: Walk, Hike, or Run for PCOS Awareness, co-hosted by PCOS Sisters & PCOS Challenge: The National Association for PCOS Awareness. How your audience can support those with PCOS and raise awareness of PCOS. PCOS Sisters Telehealth Clinic & Wellness Center: who we are and the services we provide. The PCOS condition, diagnosis, symptoms, and treatments. Dr. Johnson’s personal experience with PCOS. To coordinate interviews, please reply to this email or contact Chelsey Gilbert at pr@pcossisters.com or 904-586-1964. You can download the PCOS Sisters Media Kit here. ### About PCOS Sisters Telehealth Clinic & Wellness Center Having battled her own PCOS for years, Dr. Lynsey Johnson, DNP, FNP-C, CEO/Founder, founded PCOS Sisters Telehealth Clinic & Wellness Center, a multi-state telehealth PCOS-specializing practice now serving 9 states, to allow PCOS women nationwide to receive care from the comfort of their own home. Dr. Johnson and her team at PCOS Sisters help many women manage the root cause and symptoms of their condition.

Dr. Yoon Hang “John” Kim is a board-certified integrative medicine physician with over 20 years of clinical experience dedicated to root-cause, patient-centered care. He is widely recognized as one of the leading clinical experts on Low-Dose Naltrexone (LDN) therapy, having authored three books and more than 20 articles on the subject, and leads the LDN Support Group—a thriving community of over 7,000 members. Dr. Kim completed his Integrative Medicine Fellowship at the University of Arizona’s Andrew Weil Center for Integrative Medicine, where he trained under the mentorship of Dr. Andrew Weil as a prestigious Osher Fellow. He holds board certifications in both Preventive Medicine and Integrative/Holistic Medicine, along with certification in Medical Acupuncture from UCLA. He was also a scholarship recipient from the Institute for Functional Medicine (IFM), further deepening his expertise in functional medicine approaches to complex chronic conditions. His clinical expertise spans integrative oncology—informed by deeply personal experience supporting family members who are now cancer survivors—chronic pain management, and the treatment of complex conditions including SIBO, MCAS, and autoimmune disorders. He brings a unique combination of conventional medical rigor and evidence-based complementary therapies to every patient encounter. Dr. Kim is the founder of Direct Integrative Care, a membership-based telemedicine practice that deliberately limits enrollment to ensure deep, personalized physician-patient relationships. His practice serves patients across six states—Iowa, Illinois, Missouri, Texas, Georgia, and Florida—operating entirely outside the constraints of insurance systems to preserve clinical independence and patient-first decision-making. A featured speaker at the LDN Research Trust conferences, Dr. Kim is a passionate educator who shares his expertise through his clinical and professional websites, a YouTube channel, and educational platforms including LDNSupportGroup.com. His personal motto—“Luck favors the prepared bold”—reflects his commitment to courage, preparation, and innovation in medicine.

Dina Alsaadouni, MBA, is a strategic healthcare operations leader, healthcare innovation researcher, and independent inventor with over a decade of experience in healthcare management, digital transformation, patient engagement, and quality improvement. She has held leadership roles across private healthcare organizations in Saudi Arabia, driving operational excellence, service optimization, and patient-centered care initiatives. Her work bridges healthcare operations with emerging technologies, focusing on digital health, artificial intelligence, clinical workflow optimization, healthcare quality, patient safety, and sustainable healthcare innovation. She is the inventor of multiple healthcare technologies, with patent applications filed through the Saudi Authority for Intellectual Property (SAIP), reflecting her commitment to developing practical solutions for real-world healthcare challenges. Dina is also a published author and thought leader whose articles explore healthcare strategy, digital transformation, and medical innovation. Her research on patient engagement has been published in peer-reviewed literature, and her commentary has appeared in regional media discussing the future of healthcare innovation. She actively contributes to conversations on how technology, evidence-based management, and operational leadership can strengthen healthcare systems and support Saudi Vision 2030. Her professional interests include healthcare operations, digital health transformation, health informatics, healthcare quality, patient safety, AI in healthcare, innovation management, and healthcare policy.

I am the Founder and CEO of RCR|HUB, a U.S.-based platform that connects healthcare organizations with their Revenue Cycle partners (vendors) through education, awareness, and collaboration in healthcare revenue cycle management. I have more than 20 years of experience in healthcare marketing and technology, with a particular focus on Revenue Cycle Management strategies, AI-powered visibility, SEO/GEO, vendor positioning, automation, and the adoption of healthcare technology. Through my work with RCR|HUB, I provide solutions to help your organization improve discoverability, industry awareness, and connectivity.